Heparin's 'potential to improve pregnancy rates and outcomes' is not evidence-based

Human Reproduction Update

Volumn 16, Issue 2, 2009, Pages 225-227

  Ricci, Giuseppe ^a   Giolo, Elena ^a   Simeone, Roberto ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

CLINICAL TRIAL; EMBRYO TRANSFER; EVIDENCE BASED MEDICINE; FERTILIZATION IN VITRO; GENETIC POLYMORPHISM; HUMAN; HYPERHOMOCYSTEINEMIA; INTRACYTOPLASMIC SPERM INJECTION; LETTER; LIVE BIRTH; LOW DRUG DOSE; PATIENT SELECTION; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; THROMBOPHILIA; TREATMENT FAILURE;

EVIDENCE-BASED MEDICINE; FEMALE; HEPARIN; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY OUTCOME; REPRODUCTIVE TECHNIQUES, ASSISTED; THROMBOPHILIA; TREATMENT FAILURE;

EID: 77950169752     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmp044     Document Type: Letter

References (16)

1. de Moerloose P, Reber G. Antiphospholipid antibodies: do we still need to perform anticardiolipin ELISA assays? J Thromb Haemost 2004; 2:1071-1073.
2. Dobson AT, Davis RM, Rosen MP, Shen S, Rinaudo PF, Chan J, Cedars MI. Methylenetetrahydrofolate reductase C677T and A1298C variants do not affect ongoing pregnancy rates following IVF. Hum Reprod 2007; 22:450-456; Epub 2006 Oct 19.
3. Haggarty P, McCallum H, McBain H, Andrews K, Duthie S, McNeill G, Templeton A, Haites N, Campbell D, Bhattacharya S. Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet 2006;367:1513-1519.
4. Kutteh WH, Yetman DL, Chantilis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin. Hum Reprod 1997;12:1171-1175.
5. Lindqvist PG, Merlo J. Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence? J Thromb Haemost 2005; 3:221-223.
6. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
7. Nelson SM, Greer IA. The potential role of heparin in assisted conception. Hum Reprod Update 2008;14:623-645; Epub 2008 Aug 12.
8. Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF, Khader YS. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod 2006; 21:2694-2698.
9. Qublan H, Amarin Z, Dabbas M, Farraj AE, Beni-Merei Z, Al-Akash H, Bdoor AN, Nawasreh M, Malkawi S, Diab F et al. Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial. Hum Fertil (Camb) 2008;11:246-253.
10. Rey E, David M. The use of LMWH in pregnancies at risk: new evidence or perception? J Thromb Haemost 2005;3:782-783.
11. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361:901-908.
12. Schenk LM, Butler L, Morris JP, Cox B, Lecte J, Abuhamed A, Ochninger S, Toner JP, Muasher S. Heparin and aspiring treatment yield higher implantation rates in IVF patients with antiphospholipid antibody seropositivity compared to untreated seronegative patients. Am Soc Reprod Med 1996.
13. Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P. Immunology: high fecundity rates following in- vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Hum Reprod 1994;9:2278-2283.
14. Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Ching W. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol 1998;40:74-82.
15. Stern C, Chamley L, Norris H, Hale L, Baker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril 2003;80:376-383.
16. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337: 1223-1226.